Comparison between Metropolis Healthcare IPO and Neogen Chemicals IPO.
Metropolis Healthcare IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Neogen Chemicals IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Metropolis Healthcare IPO is up to ₹1,204.29 Cr whereas the issue size of the Neogen Chemicals IPO is up to ₹132.35 Cr. The final issue price of Metropolis Healthcare IPO is ₹880.00 per share and of Neogen Chemicals IPO is ₹215.00 per share.
| Metropolis Healthcare IPO | Neogen Chemicals IPO | |
|---|---|---|
| Face Value | ₹2 per share | ₹10 per share |
| Issue Price (Lower) | ₹877.00 per share | ₹212.00 per share |
| Issue Price (Upper) | ₹880.00 per share | ₹215.00 per share |
| Issue Price (Final) | ₹880.00 per share | ₹215.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 17 shares | 65 shares |
| Fresh Issue Size | 0 shares | 32,55,813 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹70.00 Cr |
| OFS Issue Size | 1,36,85,095 shares | 29,00,000 shares |
| OFS Issue Size (Amount) | up to ₹1,204.29 Cr | up to ₹62.35 Cr |
| Issue Size Total | 1,36,85,095 shares | 61,55,813 shares |
| Issue Size Total (Amount) | up to ₹1,204.29 Cr | up to ₹132.35 Cr |
Metropolis Healthcare IPO opens on Apr 03, 2019, while Neogen Chemicals IPO opens on Apr 24, 2019. The closing date of Metropolis Healthcare IPO and Neogen Chemicals IPO is Apr 05, 2019, and Apr 26, 2019, respectively.
| Metropolis Healthcare IPO | Neogen Chemicals IPO | |
|---|---|---|
| Anchor Bid Date | Apr 02, 2019 | Apr 23, 2019 |
| Issue Open | Apr 03, 2019 | Apr 24, 2019 |
| Issue Close | Apr 05, 2019 | Apr 26, 2019 |
| Basis Of Allotment (Tentative) | Apr 10, 2019 | May 03, 2019 |
| Initiation of Refunds (Tentative) | Apr 11, 2019 | May 06, 2019 |
| Credit of Share (Tentative) | Apr 12, 2019 | May 07, 2019 |
| Listing date (Tentative) | Apr 15, 2019 | May 08, 2019 |
| Anchor Lockin End date 1 | May 10, 2019 | Jun 02, 2019 |
| Anchor Lockin End date 2 | Jul 09, 2019 | Aug 01, 2019 |
Metropolis Healthcare IPO P/E ratio is , as compared to Neogen Chemicals IPO P/E ratio of .
| Metropolis Healthcare IPO | Neogen Chemicals IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 99.71 | |||||
| Promoter Shareholding (Post-Issue) | 49.44 | |||||
| P/E Ratio | ||||||
| Market Cap | ₹4415.72 Cr. | ₹501.69 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Metropolis Healthcare IPO Retail Individual Investors (RII) are offered 13,38,509 shares while in Neogen Chemicals IPO retail investors are offered 13,38,509 shares. Qualified Institutional Buyers (QIB) are offered 40,15,529 shares in Metropolis Healthcare IPO and 12,31,191 shares in Neogen Chemicals IPO.
| Metropolis Healthcare IPO | Neogen Chemicals IPO | |
|---|---|---|
| Anchor Investor Reservation | 60,23,293 shares | 18,46,715 shares |
| Market Maker Reservation | ||
| QIB | 40,15,529 shares | 12,31,191 shares |
| NII | 20,07,764 shares | 9,23,372 shares |
| RII | 13,38,509 shares | 21,54,535 shares |
| Employee | 3,00,000 shares | |
| Others | ||
| Total | 1,36,85,095 shares | 61,55,813 shares |
Metropolis Healthcare IPO subscribed 5.83x in total, whereas Neogen Chemicals IPO subscribed 41.07x.
| Metropolis Healthcare IPO | Neogen Chemicals IPO | |
|---|---|---|
| QIB (times) | 8.88x | 30.49x |
| NII (times) | 3.03x | 113.88x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 2.15x | 15.86x |
| Employee (times) | 0.05x | |
| Other (times) | ||
| Total (times) | 5.83x | 41.07x |
